Blue Bear Ventures
San Francisco · Seed · 3 people tracked
Investment thesis
Co-founder-focused fund for lab-based teams at the health–climate intersection (gene therapy, synthetic biology, batteries), offering deep access to UC Berkeley, UCSF, MIT and Stanford research and scientist-founders.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website
Patrick Scaglia brings a practitioner's perspective from senior R&D and engineering leadership at Hewlett-Packard, co-founded UC Berkeley's CITRIS Foundry for deep‑tech, and chairs Y Combinator Research's Human Advancement Research Community.
Deepak built and ran UC Berkeley’s CITRIS Foundry deep‑tech accelerator and, as Startup Director, Lecturer and Leadership Coach at Haas, serves as an embedded leadership coach for academic spinouts.
What they invest in
from 7 of 22 portfolio companiesHealthtech ×4AI & Machine Learning ×3Biotech ×3Medical Devices ×3Deep Tech ×2Hardware ×2Developer Tools ×1Digital Health ×1
HQs:United States×5
Investments · 22 tracked
founders shown can be your intro pathCorrelia Biosystems develops microscale tools for quantifying biomolecules from small blood samples, enabling protein expression monitoring for pharmaceutical research and diagnostics.
HardwareHealthtechMedical DevicesSan Francisco, US
Akwasi Apori(Founder)inKursad Araz(Founder/CTO)inSamuel Tia(Founder)in
Numericcal provides machine learning software for detecting anomalies, tracking assets, and managing workforce activities in automotive and manufacturing facilities, processing video and audio data across on-premises and cloud infrastructure to reduce operating costs.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
BiotechHealthtechSan Francisco, US
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)Joshua Schwochert(Co-Founder & CSO)Vasudev Bailey(Director)
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Frequently asked questions
- What stage does Blue Bear Ventures invest at?
- Blue Bear Ventures invests at the Seed stage.
- What is Blue Bear Ventures's typical check size?
- Blue Bear Ventures typically writes checks of $100K – $400K.
- What sectors does Blue Bear Ventures focus on?
- Blue Bear Ventures focuses on Biotech, Climate Tech, Deep Tech, Hardware, Healthtech, New Materials.
- Where is Blue Bear Ventures located?
- Blue Bear Ventures is headquartered in San Francisco, US.
- Does Blue Bear Ventures lead rounds?
- Blue Bear Ventures typically participates in rounds rather than leading them.
Similar investors
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
VantagePoint Capital Partners is a global venture investor backing companies from startup through scale-up, with a particular focus on energy innovation and efficiency.
Sarsia is an early-stage venture capital firm based in Norway that invests in companies advancing a greener and healthier future, focusing on life sciences and sustainable technology.
Vespucci Partners is an investment firm that emphasizes sustainability and ESG principles across its portfolio, seeking startups and investments that demonstrate responsible, sustainable business practices.